• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial 
    •   QMRO Home
    • Wolfson Institute of Preventive Medicine
    • Centre for Cancer Prevention
    • Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial
    •   QMRO Home
    • Wolfson Institute of Preventive Medicine
    • Centre for Cancer Prevention
    • Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial

    Volume
    151
    Pagination
    309 - 318
    DOI
    10.1007/s10549-015-3397-0
    Journal
    BREAST CANCER RESEARCH AND TREATMENT
    Issue
    2
    ISSN
    0167-6806
    Metadata
    Show full item record
    Authors
    Mote, PA; Gompel, A; Howe, C; Hilton, HN; Sestak, I; Cuzick, J; Dowsett, M; Hugol, D; Forgez, P; Byth, K
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/7627
    Collections
    • Centre for Cancer Prevention [740]
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.